We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current AFMD market cap is 75.12M. The company's latest EPS is EUR -7.0938 and P/E is -0.70.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 15.01M | 11.93M | 4.92M | 2.11M | 1.96M |
| Operating Income | -34.63M | -30.11M | -31.46M | -31.76M | -38.05M |
| Net Income | -16.49M | -33.44M | -31.98M | -29.4M | -24.36M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 21.68M | 28.99M | 41.68M | 42.77M | 12.97M |
| Operating Income | -32.38M | -34.72M | -64.03M | -88.12M | -106.66M |
| Net Income | -32.37M | -41.37M | -57.52M | -86M | -105.94M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 236.4M | 200.51M | 167.96M | 134.71M | 120.46M |
| Total Liabilities | 55.3M | 47.6M | 42.87M | 35.79M | 44.04M |
| Total Equity | 181.1M | 152.92M | 125.09M | 98.93M | 76.42M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 112.36M | 175.73M | 225.14M | 200.51M | 97.16M |
| Total Liabilities | 73.69M | 103.73M | 89.18M | 47.6M | 39.35M |
| Total Equity | 38.67M | 71.99M | 135.95M | 152.92M | 57.81M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -73.93M | -104.89M | -33.24M | -66.57M | -84.83M |
| Investing | 3.48M | 5.61M | -8k | -11k | -37.47M |
| Financing | 89.14M | 88.56M | -634k | -3.21M | -4.82M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -29.06M | -19.4M | -86.59M | -104.89M | -110.27M |
| Investing | 4.34M | 8.01M | -3.85M | 5.61M | -36.06M |
| Financing | 26.04M | 69.25M | 133.58M | 88.56M | -6.22M |
| Market Cap | 75.12M |
| Price to Earnings Ratio | -0.70 |
| Price to Sales Ratio | 5.76 |
| Price to Cash Ratio | 1.94 |
| Price to Book Ratio | 1.29 |
| Dividend Yield | - |
| Shares Outstanding | 14.93M |
| Average Volume (1 week) | 63.67k |
| Average Volume (1 Month) | 107.99k |
| 52 Week Change | -40.12% |
| 52 Week High | 11.10 |
| 52 Week Low | 2.235 |
| Spread (Intraday) | 0.32 (6.36%) |
| Company Name | Affimed NV |
| Address |
technologiepark im neuenheimer feld 582 heidelberg 69120 |
| Website | https://www.affimed.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
